RHOEN-KLINIKUM AG (RHK.DE) Stock Price, Forecast & Analysis

Europe Frankfurt Stock Exchange FRA:RHK • DE0007042301

13.2 EUR
+0.1 (+0.76%)
Last: Jan 30, 2026, 07:00 PM

RHK.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap883.87M
Revenue(TTM)1.69B
Net Income(TTM)37.68M
Shares66.96M
Float3.65M
52 Week High16.4
52 Week Low11.2
Yearly Dividend0
Dividend Yield0.76%
EPS(TTM)0.57
PE23.16
Fwd PE17.27
Earnings (Next)03-26
IPO1989-11-27
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Facilities
RHK.DE short term performance overview.The bars show the price performance of RHK.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8

RHK.DE long term performance overview.The bars show the price performance of RHK.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 20 30

The current stock price of RHK.DE is 13.2 EUR. In the past month the price increased by 3.94%. In the past year, price decreased by -9.59%.

RHOEN-KLINIKUM AG / RHK Daily stock chart

RHK.DE Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to RHK.DE. When comparing the yearly performance of all stocks, RHK.DE is a bad performer in the overall market: 61.69% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

RHK.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to RHK.DE. RHK.DE has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RHK.DE Financial Highlights

Over the last trailing twelve months RHK.DE reported a non-GAAP Earnings per Share(EPS) of 0.57. The EPS decreased by -15.41% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.28%
ROA 2.02%
ROE 2.9%
Debt/Equity 0.09
Chartmill High Growth Momentum
EPS Q2Q%3.33%
Sales Q2Q%8.37%
EPS 1Y (TTM)-15.41%
Revenue 1Y (TTM)9.1%

RHK.DE Forecast & Estimates

7 analysts have analysed RHK.DE and the average price target is 14.45 EUR. This implies a price increase of 9.47% is expected in the next year compared to the current price of 13.2.

For the next year, analysts expect an EPS growth of 4.3% and a revenue growth 6.74% for RHK.DE


Analysts
Analysts74.29
Price Target14.45 (9.47%)
EPS Next Y4.3%
Revenue Next Year6.74%

RHK.DE Ownership

Ownership
Inst Owners0.55%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About RHK.DE

Company Profile

RHK logo image Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 19,041 full-time employees. The firm operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.

Company Info

RHOEN-KLINIKUM AG

Schlossplatz 1

Bad Neustadt an der Saale BAYERN DE

Employees: 14067

RHK Company Website

RHK Investor Relations

Phone: 499771650

RHOEN-KLINIKUM AG / RHK.DE FAQ

Can you describe the business of RHOEN-KLINIKUM AG?

Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 19,041 full-time employees. The firm operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.


What is the stock price of RHOEN-KLINIKUM AG today?

The current stock price of RHK.DE is 13.2 EUR. The price increased by 0.76% in the last trading session.


What is the dividend status of RHOEN-KLINIKUM AG?

RHOEN-KLINIKUM AG (RHK.DE) has a dividend yield of 0.76%. The yearly dividend amount is currently 0.


What is the ChartMill technical and fundamental rating of RHK stock?

RHK.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Is RHOEN-KLINIKUM AG (RHK.DE) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RHK.DE.


Can you provide the market cap for RHOEN-KLINIKUM AG?

RHOEN-KLINIKUM AG (RHK.DE) has a market capitalization of 883.87M EUR. This makes RHK.DE a Small Cap stock.


Can you provide the ownership details for RHK stock?

You can find the ownership structure of RHOEN-KLINIKUM AG (RHK.DE) on the Ownership tab.